Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium

14Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A chromogenic medium for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium, VRESelect, was compared to bile esculin azide agar with 6 μg/ml vancomycin (BEAV) for the isolation of vancomycin-resistant enterococci (VRE) from stool specimens. At 24 to 28 h, VRESelect demonstrated 98.7% (confidence interval [CI], 96.1 to 99.7%) sensitivity and 99.0% (CI, 98.0 to 99.6%) specificity versus 85.1% (CI, 79.8 to 89.5%) and 90.1% (CI, 79.8 to 89.5%) sensitivity and specificity, respectively, for BEAV. Copyright © 2013, American Society for Microbiology.

Cite

CITATION STYLE

APA

Anderson, N. W., Buchan, B. W., Young, C. L., Newton, D. W., Brenke, C., Lapsley, L., … Ledeboer, N. A. (2013). Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. Journal of Clinical Microbiology, 51(8), 2758–2760. https://doi.org/10.1128/JCM.00979-13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free